|
|
Article: Dr. Harry Kovelman Joins Ferring Pharmaceuticals as Associate Medical Director for Orthopaedics.
- Article from:
- Biotech Week
- Article date:
- November 11, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Ferring Pharmaceuticals Inc. announces the appointment of Harry F. Kovelman, MD as Associate Medical Director for Orthopaedics. Dr. Kovelman will be responsible for medical affairs for EUFLEXXA=AE (1% sodium hyaluronate), a treatment for knee pain due to osteoarthritis, as well as Ferring's expanding line of orthopaedic products (see also Orthopedics).
"Dr. Kovelman is exceptionally well qualified to fill this role," said Edward Trott, MD, Vice President, Medical Affairs. "His experience and knowledge in the field of orthopaedic medicine will provide valuable insight as we continue to build upon our success with EUFLEXXA=AE."
Dr. Kovelman joins Ferring ...